🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →
S&P 500: 759.97 -0.5% NASDAQ 100: 704.40 0.0% Dow Jones: 534.08 -0.5%

Washington Growth Strategies - Q2 2026 13F Filings

WA

Washington Growth Strategies LLC

CIK: 0002044575
Address: District Of Columbia Washington 1200 G Street Nw 8Th Floor
$180.11 M
Portfolio Value
62
Assets Held
Reporting Period: Q2 2026
Filing Status:
Active
Last Updated: 10/19/2026

Portfolio Summary (Q2 2026)

View Full Portfolio Analysis

Top Buys

Q2 2026
1. JNJ Johnson & Johnson
+$435,813
2. TMO Thermo Fisher Scientific
+$422,146
3. VO Vanguard Mid-Cap Etf
+$393,746.25
4. GILD Gilead Sciences
+$386,854
5. NVDA Nvidia Corporation
+$383,172.63

Top Sells

Q2 2026
1. GLD Spdr Gold Shares
−$222,030
2. FXI Ishares China Large-Cap Etf
−$174,977.05
3. SPY Spdr S&P 500 Etf Trust
−$169,516.79
4. KYIV Kyivstar Group
−$149,523
5. GLIN Vaneck India Growth Leaders Etf
−$100,672.55

Asset Allocation

Stocks/ETFs
+17.68%
$180.11 M 100.00%
Options
$0 0.00%
Debt
$0 0.00%
Other
$0 0.00%

Sector Allocation (Stocks)

Washington Growth Strategies Q2 2026 Filing Summary

Washington Growth Strategies LLC filed its 13F report for Q2 2026 on July 16, 2026. The portfolio totaled 180.11 M reflecting a +17.68% change from the prior quarter, spanning 62 assets. The top 10 holdings comprised 64.9% of the portfolio, with Financials as the largest sector allocation. Quarterly activity included 7 new positions and 2 complete exits.

Report Type

Status

Data Summary

Items:

Total Value:

Actions

Issuer Name Class Value Shares Option Type

FAQs for Washington Growth Strategies’s Q2 2026 Filing

Washington Growth Strategies submitted their Form 13F-HR for the Q2 2026 period on 07/16/2026. This was the only submission for the quarter.

In the Q2 2026 filing, Washington Growth Strategies reported a managed portfolio value of 180.11 M, consisting of 62 individual positions.

This page displays the raw filing documents. To see which stocks Washington Growth Strategies bought or sold during Q2 2026, please visit Washington Growth Strategies's Portfolio Analysis page.